Published in Agents Actions Suppl on January 01, 1983
Leukotrienes in inflammation. Agents Actions (1986) 1.20
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses. Clin Exp Immunol (1983) 1.01
Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res (1984) 0.87
Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes. Arch Dermatol Res (1985) 0.78
Chemotaxis: basic aspects of methodology, mechanisms and pathology. Arch Dermatol Res (1983) 0.75
Cytochrome P-450-dependent production of chemotactic arachidonate metabolites from human neutrophils. Arch Dermatol Res (1984) 0.75
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44
Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol (1995) 1.54
Mast cells. Int J Dermatol (1995) 1.52
Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol (1995) 1.50
Human mast cells produce IL-8. J Immunol (1993) 1.44
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39
[Urticaria pigmentosa and mastocytosis]. Dtsch Med Wochenschr (1998) 1.38
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol (1994) 1.30
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol (1994) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol (1981) 1.15
Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol (1984) 1.13
Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol (1994) 1.08
Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol (1993) 1.08
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol (1998) 1.06
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res (1994) 0.98
In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. Prostaglandins (1985) 0.98
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. J Immunol Methods (1988) 0.97
Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol (1993) 0.97
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Hair growth induction by substance P. Lab Invest (1994) 0.96
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol (1984) 0.95
Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro. Prostaglandins (1986) 0.95
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol (1994) 0.94
Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol (2001) 0.94
Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst (1995) 0.92
Chemotactic leukotrienes in psoriasis. Lancet (1982) 0.92
Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol (1981) 0.91
Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br J Dermatol (1994) 0.91
Ultrastructure of inclusions in peripheral blood mononuclear cells in sarcoidosis. Am J Pathol (1975) 0.91
Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res (1995) 0.91
P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol (1995) 0.91
Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study. J Am Acad Dermatol (1991) 0.90
In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol (1983) 0.90
Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids (1981) 0.90
Evidence that water acts as a carrier for an epidermal antigen in aquagenic urticaria. J Am Acad Dermatol (1986) 0.90
Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells. Int Arch Allergy Immunol (1996) 0.90
Morphology of the cellular infiltrate in delayed pressure urticaria. J Am Acad Dermatol (1985) 0.89
Mast cells as modulators of hair follicle cycling. Exp Dermatol (1995) 0.89
Foreign-body granuloma and IgE-pseudolymphoma after multiple bee stings. Br J Dermatol (1994) 0.89
Development of human connective tissue mast cells from purified blood monocytes. Immunology (1984) 0.89
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol (1995) 0.89
Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis. Br J Dermatol (1988) 0.88
Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun (1995) 0.88
Detection of human papillomaviruses in paraffin-embedded condylomata acuminata--comparison of immunohistochemistry, in situ hybridization, and polymerase chain reaction. J Invest Dermatol (1991) 0.88
Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells. Immunology (1994) 0.87
[New perspectives in hair research: in search of the "biological clock" of the hair cycle]. Hautarzt (1992) 0.87
Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res (1984) 0.87
An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). J Clin Pathol (2006) 0.86
Primary leiomyosarcoma of the skin. A histological and immunohistochemical analysis. Acta Derm Venereol (1993) 0.86
Clinical, pharmacological and immunological aspects of delayed pressure urticaria. Br J Dermatol (1984) 0.86
In vitro differentiation of rat peritoneal macrophages into mast cells: an enzymecytochemical study. Blut (1982) 0.86
Interleukin-6 expression in the skin of patients with lupus erythematosus. Exp Dermatol (1995) 0.86
Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies. Dermatologica (1988) 0.85
Correlation of proteolytic activities of organ cultured intact mouse skin with defined hair cycle stages. J Dermatol Sci (1994) 0.85
Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol (1995) 0.85
Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes. J Invest Dermatol (1985) 0.85
Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol (1994) 0.85
Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol (1994) 0.85
Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose. J Invest Dermatol (1982) 0.84
GM-CSF downmodulates c-kit, Fc(epsilon)RI(alpha) and GM-CSF receptor expression as well as histamine and tryptase levels in cultured human mast cells. Arch Dermatol Res (2001) 0.84
Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.84
Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol (1984) 0.84
Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications. Br J Cancer (2000) 0.83
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer (1994) 0.83
Human mast cells produce and differentially express both soluble and membrane-bound stem cell factor. Scand J Immunol (1999) 0.83
[Annular elastolytic giant cell granuloma with a spontaneous healing tendency]. Hautarzt (1995) 0.83
Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.83
Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology (1998) 0.83
Amelanotic malignant melanoma presenting as malignant schwannoma. Br J Dermatol (1993) 0.83
Early IgE-dependent release of IL-4 and IL-13 from leukocytes is restricted to basophils: a comparison with other granulocytes and mononuclear cells. Inflamm Res (2000) 0.83
Regulation and possible function of axl expression in immature human mast cells. Ann Hematol (1998) 0.83
Expression of growth factor receptors on human melanoma cells: comparison of modulating effects of interferons and retinoids. Exp Dermatol (1993) 0.82
Mast cells in melanocytic tumours. Arch Dermatol Res (1995) 0.82
A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica (1983) 0.82
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma. J Cancer Res Clin Oncol (1979) 0.82
Calcineurin antagonists differentially affect mediator secretion, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils. Clin Exp Allergy (2003) 0.82
In vitro generation of eosinophil chemotactic factor from human and murine mononuclear phagocytes. Scand J Immunol (1981) 0.82
The differentiation-related upregulation of aryl hydrocarbon receptor transcript levels is suppressed by retinoic acid. Biochem Biophys Res Commun (1995) 0.82
Modulation of eosinophil chemotaxis and eosinophil chemotactic factor release by concanavalin A. Int Arch Allergy Appl Immunol (1978) 0.81
Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue. J Invest Dermatol (2000) 0.81
[Biology of the hair follicle]. Hautarzt (1994) 0.81
Neutrophil-derived eosinophil chemotactic factor production induced by immune complexes. Int Arch Allergy Appl Immunol (1981) 0.81
Histamine releasability of basophils and skin mast cells in chronic urticaria. Allergy (1996) 0.81
Ketotifen in cholinergic urticaria. J Allergy Clin Immunol (1990) 0.81